https://www.selleckchem.com/pr....oducts/Aloxistatin.h
e complications can develop in treated and untreated patients of all ages, follow-up should occur during the patient`s lifetime. Coronary artery fistulae are usually asymptomatic, and medical therapy with long term follow up is the first line treatment. Fistulae that cause hemodynamically significant shunting, chamber enlargement, or visible symptoms should be closed at an early age. This study shows that transcatheter closure is a safe treatment option for CAF that may be performed with high success. Also, it should be known that s
Like
Comment
Share
